Cambridge, MA, United States of America

Maroof Alam

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sarepta Therapeutics, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maroof Alam: Innovator in Cell Culture Technology

Introduction

Maroof Alam is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cell culture technology, particularly in the expansion of adherent cells. His innovative approaches have the potential to enhance various applications in biotechnology and medicine.

Latest Patents

Maroof Alam holds a patent for a method titled "Suspension mode seed train development for adherent cells." This patent describes a process for seed train expansion of adherent cells, which involves culturing cells in a serum-supplemented growth medium within a N-2 vessel. The method includes removing the cells from the serum-supplemented medium, inoculating them into a serum-free growth medium in a N-1 vessel, and culturing the cells under suspension conditions. Notably, the adherent cells produced by this method can be utilized to generate viral vectors, including AAV vectors.

Career Highlights

Maroof Alam is currently associated with Sarepta Therapeutics, Inc., where he applies his expertise in cell culture and biotechnology. His work focuses on advancing methodologies that can lead to improved therapeutic outcomes in various medical fields.

Conclusion

Maroof Alam's contributions to cell culture technology through his innovative patent demonstrate his commitment to advancing biotechnological applications. His work has the potential to significantly impact the development of viral vectors and other therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…